Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / A Prospective Study on Myocardial Injury after BNT162b2 mRNA COVID-19 Fourth Dose Vaccination in Healthy Persons.

< BACK TO ARCHIVE


2022 Sep 13


Eur J Heart Fail


http://www.ncbi.nlm.nih.gov/pubmed/36097844?dopt=Abstract

A Prospective Study on Myocardial Injury after BNT162b2 mRNA COVID-19 Fourth Dose Vaccination in Healthy Persons.

Authors

A Prospective Study on Myocardial Injury after BNT162b2 mRNA COVID-19 Fourth Dose Vaccination in Healthy Persons.
Levi N, Moravsky G, Weitsman T, Amsalem I, Bar-Sheshet Itach S, Algur N, Lapidus I, Mitz O, Glikson M, Wiener-Well Y, Hasin T
Eur J Heart Fail. 2022 Sep 13.
PMID: 36097844.

Abstract

To prospectively evaluate the incidence of myocardial injury after the administration of the fourth dose BNT162b2 mRNA vaccine (Pfizer-BioNTech) against COVID-19.
Read This Paper